Pharmafile Logo
Pharmafocus logo
Advanced Search

Levin

Showing 6 posts of 6 posts found.

Dr Phillip Frost image

Teva chairman stepping down amid revamp

June 19, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …

News
Erez Vigodman image

Teva names new chief executive

January 9, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Levin, Teva, erez vigodman, generics

The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …

News
Levin image

Teva boss quits over Board struggles

October 31, 2013
Medical Communications, Sales and Marketing Copaxone, Levin, Teva, generics

Teva’s president and chief executive Dr Jeremy Levin has unexpectedly quit as the firm struggles with staff cuts and management …

News
Lonza image

Teva and Lonza abandon biosimilars joint venture

July 26, 2013
Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars

Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …

News
teva image

Teva revamp will see manufacturing shake-up

December 17, 2012
Manufacturing and Production Levin, Teva, manufacturing

Teva’s recent announcement of a major restructuring of its business to cut costs and maintain profitability includes a revamp of …

News
speakerwilliamsmarth

Leadership changes at Teva

November 8, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026